New Year Bumper Sale @ Rs. 1 X
Amiject 250 Injection is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Urinary Tract Infection. Secondary and off-label uses of Amiject 250 Injection have also been mentioned below.
The right dosage of Amiject 250 Injection depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Amiject 250 Injection side effects, there are can be others also. These have been listed below. Such side effects of Amiject 250 Injection normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Amiject 250 Injection has a Severe effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Amiject 250 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Amiject 250 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Dehydration, Parkinson's Disease, Hearing Loss are examples of such conditions. Other contraindications of Amiject 250 Injection have been discussed in the sections ahead.
Drug interactions for Amiject 250 Injection have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Amiject 250 Injection, it is important to know that it is safe while driving, and is habit-forming.
Amiject 250 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
2 - 12 years (Child) |
|
Is the use of Amiject 250 Injection safe for pregnant women?
Amiject should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Amiject 250 Injection safe during breastfeeding?
Information about safety of Amiject for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Amiject 250 Injection on the Kidneys?
There may be some severe side effects of Amiject on your kidney. Do not take it unless a doctor says so.
What is the effect of Amiject 250 Injection on the Liver?
Very few cases of side effects of Amiject on the liver have been reported.
What is the effect of Amiject 250 Injection on the Heart?
Amiject may have mild side effects on the heart. Most people will never see any effect on the heart.
Amiject 250 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Amiject 250 Injection unless your doctor advises you to do so -
Is this Amiject 250 Injection habit forming or addictive?
No, you will not get addicted to Amiject 250 Injection.
Is it safe to drive or operate heavy machinery when consuming?
Amiject 250 Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Amiject 250 Injection only as per medical advice.
Is it able to treat mental disorders?
No, Amiject 250 Injection is not used to treat mental disorders.
Interaction between Food and Amiject 250 Injection
It is safe to take Amiject 250 Injection with food.
Interaction between Alcohol and Amiject 250 Injection
Information about the interaction of Amiject 250 Injection and alcohol is not currently available because this topic has not been researched yet.
No, Amiject cannot be taken with penicillin. Because penicillin inactivates the Amiject by combining the beta-lactam ring of penicillin with an amino group of this drug to form amide which is biologically inactive. For this reason Amiject should not be taken with penicillin. The chances of inactivation of this drug are higher in case of renal failure because in this case concentration of penicillin is higher in the kidney for a longer time as compared to the normal renal function.
Yes, Amiject is nephrotoxic. Nephrotoxicity depends on dose and duration of therapy. Thus, nephrotoxicity is likely to occur if Amiject taken a high dose for a long time or may occur if the drug is given to a patient that already suffer from kidney problem. Nephrotoxicity associated with this drug may reduce or minimize by taking some precaution before consuming this drug like monitor kidney functions regularly and do not take it in high doses. Avoid taking Amiject with another nephrotoxic drug. If you notice any urine discoloration after taking this drug then inform your doctor immediately.
No, Amiject does not cause constipation in patients who are taking it. However, if you are experiencing constipation after taking this drug then inform your doctor and take precautionary methods such as eating fibrous foods to avoid constipation.
Discontinuing Amiject on your own can increase the chances of bacterial resistance and infection relapse. It is recommended that you always consult your doctor if you have decided to discontinue this medicine.
No, Amiject is not available in tablet form. It is available in only injectable dosage form either given by intramuscularly or intravenously depends on patient condition or severity of infections.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137